Status:

COMPLETED

Augmentation of Depression Treatment by Gamified Network Retraining

Lead Sponsor:

University Hospital Tuebingen

Conditions:

Depression Mild

Cognitive Impairment

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Major depressive disorder (MDD) is a highly prevalent and debilitating mental disorder with a high lifetime prevalence of 16-20%. Particularly for people with low socio-economic status, the existing a...

Eligibility Criteria

Inclusion

  • Full age (\> 18 years old)
  • Consent
  • German mother tongue
  • Presence of mild-to-moderate depressive symptoms (MADRS \> 10 and \< 34 and confirmation of depressive symptoms in M.I.N.I. diagnostic interview)
  • Stable or no medication with antidepressant drugs or other psychoactive agents (at least for 6 weeks)
  • No or current psychotherapy

Exclusion

  • Presence of schizophrenia / psychotic disorder (according to M.I.N.I. diagnostic interview)
  • Cognitive impairment
  • Epilepsy

Key Trial Info

Start Date :

May 14 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 15 2021

Estimated Enrollment :

32 Patients enrolled

Trial Details

Trial ID

NCT04400162

Start Date

May 14 2020

End Date

March 15 2021

Last Update

April 28 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Department of Psychiatry and Psychotherapy, University of Tübingen

Tübingen, Germany, 72076